{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:29:49Z","timestamp":1769128189923,"version":"3.49.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":539,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"DOI":"10.1513\/annalsats.202405-477ed","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T09:58:43Z","timestamp":1722506323000},"page":"1126-1128","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":2,"title":["Start Slow and Step Up or Hit Hard, Step Down? Finding the Right Initial Therapy for Chronic Obstructive Pulmonary Disease"],"prefix":"10.1093","volume":"21","author":[{"given":"David","family":"Bozaan","sequence":"first","affiliation":[{"name":"Division of Hospital Medicine and"},{"name":"Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brice","family":"Taylor","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie Parks","family":"Taylor","sequence":"additional","affiliation":[{"name":"Division of Hospital Medicine and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"key":"2026012203162169000_bib1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.5588\/ijtld.19.0397","article-title":"The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries","volume":"23","author":"Halpin","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026012203162169000_bib2","doi-asserted-by":"crossref","first-page":"e2346598","DOI":"10.1001\/jamanetworkopen.2023.46598","article-title":"Global burden of chronic obstructive pulmonary disease through 2050","volume":"6","author":"Boers","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026012203162169000_bib3","first-page":"798","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary","volume":"46","author":"Pauwels","year":"2001","journal-title":"Respir Care"},{"key":"2026012203162169000_bib4","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/S0140-6736(05)66781-5","article-title":"Alpha1-antitrypsin deficiency","volume":"365","author":"Stoller","year":"2005","journal-title":"Lancet"},{"key":"2026012203162169000_bib5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1164\/rccm.202301-0106PP","article-title":"Global Initiative for Chronic Obstructive Lung Disease 2023 report: GOLD Executive Summary","volume":"207","author":"Agust\u00ed","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203162169000_bib6","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJMoa1007285","article-title":"Lung volumes and emphysema in smokers with interstitial lung abnormalities","volume":"364","author":"Washko","year":"2011","journal-title":"N Engl J Med"},{"key":"2026012203162169000_bib7","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jama.2016.0518","article-title":"Association between interstitial lung abnormalities and all-cause mortality","volume":"315","author":"Putman","year":"2016","journal-title":"JAMA"},{"key":"2026012203162169000_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4104\/pcrj.2012.00092","article-title":"Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD","volume":"22","author":"Price","year":"2013","journal-title":"Prim Care Respir J"},{"key":"2026012203162169000_bib9","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1513\/AnnalsATS.202311-990OC","article-title":"Benefit\u2013harm analysis of earlier initiation of triple therapy for prevention of acute exacerbation in patients with chronic obstructive pulmonary disease","volume":"21","author":"Mountain","year":"2024","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203162169000_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/0272989X18824098","article-title":"Development and Validation of the Evaluation Platform in COPD (EPIC): a population-based outcomes model of COPD for Canada","volume":"39","author":"Sadatsafavi","year":"2019","journal-title":"Med Decis Making"},{"key":"2026012203162169000_bib11","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1183\/09031936.00200212","article-title":"Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study","volume":"42","author":"Bateman","year":"2013","journal-title":"Eur Respir J"},{"key":"2026012203162169000_bib12","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","article-title":"Once-daily single-inhaler triple versus dual therapy in patients with COPD","volume":"378","author":"Lipson","year":"2018","journal-title":"N Engl J Med"},{"key":"2026012203162169000_bib13","doi-asserted-by":"crossref","first-page":"k4388","DOI":"10.1136\/bmj.k4388","article-title":"Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis","volume":"363","author":"Zheng","year":"2018","journal-title":"BMJ"},{"key":"2026012203162169000_bib14","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.21037\/jtd.2018.06.151","article-title":"Systematic review of inhaled corticosteroid withdrawal effects in chronic obstructive pulmonary disease, and comparison with two \u201creal-life\u201d studies","volume":"10","author":"Ye","year":"2018","journal-title":"J Thorac Dis"},{"key":"2026012203162169000_bib15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S2468-1253(24)00034-7","article-title":"A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn\u2019s disease (PROFILE): a multicentre, open-label randomised controlled trial","volume":"9","author":"Noor","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/21\/8\/1126\/66008444\/annalsats_21_8_1126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/21\/8\/1126\/66008444\/annalsats_21_8_1126.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:17:30Z","timestamp":1769069850000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/21\/8\/1126\/8380691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":15,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,1]]},"published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202405-477ed","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,8,1]]},"assertion":[{"value":"2024-08-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}